header
Image from OpenLibrary

The association between the ras association domain family 1 isoform a polymorphism and hepatocellular carcinoma in an Egyptian population / Marwa Nagi Ramadan Elfiki ; Supervised Ola Abdelmonaem Elsesy , Faten Mohamed Tharwat Elshanawani , Amaal Abdo Abdelaal

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Marwa Nagi Ramadan Elfiki , 2015Description: 124 P. : charts , facsimiles ; 25cmOther title:
  • في حالات سرطان الخلايا الكبدية RASSF1A Ala133Ser التغيير في التركيب الجيني للجين المسئول عن قمع الورم [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide. Because of its high fatality rates, the incidence and mortality rate are approximately equal. Thus, the pathogenesis of liver diseases has been extensively studied focusing on genetic factors which have a major role. One of these genetic factors is suppressor gene RASSF1A, particularly single nucleotide polymorphism in RASSF1A gene called Ala133Ser (rs2073498). Objective: To study if Ala133Ser polymorphism of the RASSF1A gene is associated with increased risk of HCC in Egyptian population. Methods: The study included 50 patients with HCC and 50 healthy subjects. They were subjected to genotyping for RASSF1A gene Ala133Ser polymorphism using Restriction fragment length polymorphism (RFLP) technique. Results: (Ala/Ser+ Ser/Ser) genotype frequency was significantly higher in HCC patients as compared to healthy subjects (P=0.000); also Ser allele frequency was significantly higher in HCC patients as compared to healthy subjects [OR 1.86, 95% CI (1.008-3.432)]( P= 0.032). Conclusion: The results of this study may suggest a role of RASSF1A gene Ala133Ser polymorphisms in HCC in Egyptian population.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2015.Ma.A (Browse shelf(Opens below)) Not for loan 01010110069218000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2015.Ma.A (Browse shelf(Opens below)) 69218.CD Not for loan 01020110069218000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide. Because of its high fatality rates, the incidence and mortality rate are approximately equal. Thus, the pathogenesis of liver diseases has been extensively studied focusing on genetic factors which have a major role. One of these genetic factors is suppressor gene RASSF1A, particularly single nucleotide polymorphism in RASSF1A gene called Ala133Ser (rs2073498). Objective: To study if Ala133Ser polymorphism of the RASSF1A gene is associated with increased risk of HCC in Egyptian population. Methods: The study included 50 patients with HCC and 50 healthy subjects. They were subjected to genotyping for RASSF1A gene Ala133Ser polymorphism using Restriction fragment length polymorphism (RFLP) technique. Results: (Ala/Ser+ Ser/Ser) genotype frequency was significantly higher in HCC patients as compared to healthy subjects (P=0.000); also Ser allele frequency was significantly higher in HCC patients as compared to healthy subjects [OR 1.86, 95% CI (1.008-3.432)]( P= 0.032). Conclusion: The results of this study may suggest a role of RASSF1A gene Ala133Ser polymorphisms in HCC in Egyptian population.

Issued also as CD

There are no comments on this title.

to post a comment.